[1]赵军,董重阳,李昕,等.蒙药蓝刺头抗PMOP骨组织计量学研究[J].西部中医药,2020,33(05):63-66.[doi:10.12174/j.issn.1004-6852.2020.05.18]
　ZHAO Jun,DONG Chongyang,LI Xin,et al.Research on Bone Tissue Metrology of Mongolian Medicine Lancitou Fighting Against PMOP[J].Western Journal of Traditional Chinese Medicine,2020,33(05):63-66.[doi:10.12174/j.issn.1004-6852.2020.05.18]
点击复制

蒙药蓝刺头抗PMOP骨组织计量学研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年05期
页码:
63-66
栏目:
出版日期:
2020-05-15

文章信息/Info

Title:
Research on Bone Tissue Metrology of Mongolian Medicine Lancitou Fighting Against PMOP
文章编号:
1004-6852(2020)05-0063-04
作者:
赵军，董重阳，李昕，师建平，谢静华，苏和，刘岩，莫日根
1 内蒙古自治区中医医院，内蒙古 呼和浩特 010020； 2 南京中医药大学；3 内蒙古医科大学中医学院； 4 内蒙古医科大学附属医院中医科
Author(s):
ZHAO Jun1, DONG Chongyang2,3, LI Xin4, SHI Jianping3, XIE Jinghua1, SU He1, LIU Yan4, MO Rigen1△
1 Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine, Hohehot 010020, China; 2 Nanjing University of Chinese Medicine; 3 TCM College, Inner Mongolia Medical University; 4 TCM Department, Affiliated Hospital of Inner Mongolia Me
关键词:
骨质疏松; 绝经后; 补暖补精-清镇赫依-固骨质壮骨; 骨组织; 计量研究; 蒙药; 蓝刺头; 大鼠
Keywords:
osteoporosis;  postmenopausal;  classical theory;  bone tissue;  metrology study;  mongolian medicine;  Lancitourats;  rats
分类号:
R29
DOI:
10.12174/j.issn.1004-6852.2020.05.18
文献标志码:
A
摘要:
目的：为蒙医药基于“补暖补精-清镇赫依-固骨质壮骨”经典理论防治绝经后骨质疏松症(postmenopausal osteoporosis，PMOP)提供实验依据，为蒙医药现代化提供思路。方法：将4月龄SD系SPF级健康雌性未孕大鼠49只随机分为假手术组、模型组、淫羊藿组、辅酶Q10组及蒙药蓝刺头高、中、低剂量组。采用去势方法制造PMOP模型，阴道上皮角化实验方法验证造模是否成功。术后饲养90天，模型组、假手术组生理盐水灌胃，其余各组予相应药物灌胃处死大鼠，剔取右侧完整股骨，4%多聚甲醛溶液固定保存。检测右侧股骨离体骨骨密度（bone mineral density,BMD），包括股骨近端BMD及股骨总BMD；骨组织计量（Micro-CT）方法测定骨微结构。结果：去卵巢术后各组大鼠BMD下降明显，松质骨、皮质骨骨量相继减少，皮质骨变薄；骨组织体积及骨小梁体积分数、厚度、宽度、数目及模块因素下降明显，分离度升高明显；适当剂量蒙药蓝刺头可提高大鼠骨组织体积、骨小梁体积分数、厚度、宽度、数目及模块因素，降低骨小梁分离度；有明显抗PMOP作用。结论：蒙药蓝刺头具有抗PMOP模型大鼠骨质疏松作用，能降低PMOP模型大鼠骨吸收，可为蒙医药补暖补精-清镇赫依-固骨质壮骨治法防治PMOP的科学研究提供实验依据。
Abstract:
Objective: To provide experimental reference for the prevention and treatment for postmenopausal osteoporosis (PMOP) based on the classical theory of mongolian medicine, and provide the thinking for mongolian medicine modernization. Methods: All 49 healthy rats aged four months were randomized into sham operation group, the model group, Yinyanghuo group, coenzyme Q10 group, high, moderate and low dose groups of mongolian medicine Lancitou(echinops sphaerocephalus) . PMOP models were established by castrating, vaginal cornification test was used to testify whether modeling succeeded. The model group and sham operation group were drenched with normal saline 90 days after the surgery, other groups with the corresponding herbs. Right intact femur was collected, fixed and conserved with 4% paraformldehyde solution after the rats were sacrificed. To detect bone mineral density(BMD) of right femur, including femoral proximal BMD and total BMD of the femur; bone tissue metrology was used to measure bone microstructure. Results: After ovariectomized, BMD reduced in different groups, bone mass reduced successively in spongy bone and cortical bone, cortical bone became thinner; after ovariectomized, bone tissue volume and bone trabuculae volume fraction, thickness, width, number and module in different groups lowered notably, resolution rose notably; adequate dose of mongolian medicine Lancitou could raise bone volume, bone volume/tissue volume (BV/TV), thickness, width, number and patter factor, and decrease trabuculae spacing; and it possessed remarkable anti-PMOP effects. Conclusion:Mongolian medicine Lancitou could fight against osteoporosis of PMOP rats remarkably, apparently decrease bone resorption of PMOP rat model, and it could provide experimental reference for scientific study on the prevention and treatment for PMOP by classical treatment of mongolian medicine.

相似文献/References:

[1]王一强,史鹏亮,张玉香.仙灵骨葆胶囊治疗老年骨质疏松性胸腰椎压缩性骨折的临床观察[J].西部中医药,2015,28(11):96.
[2]陈迪坤,徐展望△.经皮椎体成形术联合中药治疗骨质疏松性胸腰椎压缩骨折临床观察[J].西部中医药,2013,26(11):93.
　CHEN Dikun,XU Zhanwang.Clinical Observation on Percutaneous Vertebroplasty Combined with TCM in Treating Osteoporotic Vertebral Compression Fracture[J].Western Journal of Traditional Chinese Medicine,2013,26(05):93.
[3]王世东,龙大福,朱晨雨.鲑鱼降钙素联合仙灵骨葆治疗骨质疏松疼痛60例临床观察[J].西部中医药,2012,25(08):74.
　WANG Shi-dong,LONG Da-fu,ZHU Chen-yu.Clinical Observation on Salcalcitonin and XianLing GuBao Capsule in Treating 60 Cases of Osteoporosis Complicated with Pain[J].Western Journal of Traditional Chinese Medicine,2012,25(05):74.
[4]薄云,夏冰杰,赵丽艳,等.疏肝滋肾汤治疗绝经后女性骨关节炎的临床观察[J].西部中医药,2016,29(07):93.
　BO Yun,XIA Bingjie,ZHAO Liyan,et al.Clinical Observation on ShuGan ZiShen Tang in Osteoarthritis of the Female Patients after the Menopause[J].Western Journal of Traditional Chinese Medicine,2016,29(05):93.
[5]张彦军,邓强,王国玉,等.中医综合疗法与微创手术治疗骨质疏松性椎体压缩骨折比较研究[J].西部中医药,2018,31(01):94.
　ZHANG Yanjun,DENG Qiang,et al.Effects Comparisons of TCM Comprehensive Therapy and Minimally Invasive Surgery in Treating Osteoporotic Vertebral Compression Fractures[J].Western Journal of Traditional Chinese Medicine,2018,31(05):94.
[6]张长彪,彭冉东,赵军,等.益肾地黄汤联合利塞膦酸钠治疗肾阳虚型绝经后骨质疏松症45例[J].西部中医药,2017,30(04):1.
　ZHANG Changbiao,PENG Randong,ZHAO Jun,et al.YiShen Dihuang Tang Combined with Risedronate Sodium in the Treatment for 45 Cases of Postmenopausal Osteoporosis of Kidney Yang Deficiency Type[J].Western Journal of Traditional Chinese Medicine,2017,30(05):1.
[7]单梓梅.维、汉老年男性代谢综合征患者骨代谢相关因素分析[J].西部中医药,2017,30(08):56.
　SHAN Zimei.An Analysis of the Related Factors of Bone Metabolism of the Elderly Men with Metabolic Syndrome from Uygur Ethnic Group and the Han Nationality[J].Western Journal of Traditional Chinese Medicine,2017,30(05):56.
[8]王颢,潘剑△.仙灵骨葆胶囊治疗老年骨质疏松性腰椎压缩骨折40例[J].西部中医药,2017,30(08):89.
　WANG Hao,PAN Jian.XianLing GuBao Capsules in Treating 40 Cases of Senile Osteoporotic Compression Fracture of Lumbar Vertebra[J].Western Journal of Traditional Chinese Medicine,2017,30(05):89.
[9]杨勇萍,陈红梅.针灸联合激光治疗对骨质疏松患者后腰背痛的影响[J].西部中医药,2018,31(12):128.
　YANG Yongping,CHEN Hongmei.Effects of Acupuncture and Laser Therapy on Back Pain of the Patients with Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2018,31(05):128.
[10]王想福,陈伟国,叶丙霖,等.从“肝肾同源”理论论治绝经后妇女骨质疏松症的研究进展[J].西部中医药,2019,32(06):155.
　WANG Xiangfu,CHEN Weiguo,YE Binglin,et al.Research Progress of Treatment for Osteoporosis of Postmenopausal Women Based on the Theory of ''Same Source of Liver and Kidney ''[J].Western Journal of Traditional Chinese Medicine,2019,32(05):155.
[11]赵军,李昕,谢静华,等.蒙药蓝刺头对去卵巢大鼠BMD、E2及股骨头CYP450的作用[J].西部中医药,2022,35(04):21.[doi:10.12174/j.issn.2096-9600.2022.04.06]
　ZHAO Jun,LI Xin,XIE Jinghua,et al.Effects of Mongolian Medicine Lancitou on BMD, E2 and Femoral CYP450 of Ovariectomized Rats[J].Western Journal of Traditional Chinese Medicine,2022,35(05):21.[doi:10.12174/j.issn.2096-9600.2022.04.06]
[12]赵军,李昕,刘晋,等.蒙药蓝刺头对去卵巢大鼠TGF-β1、BMD及子宫组织形态的影响[J].西部中医药,2021,34(10):30.[doi:10.12174/j.issn.2096-9600.2021.10.07]
　ZHAO Jun,LI Xin,LIU Jin,et al.Influence of Mongolian Medicine Lancitou on TGF-β1, BMD and Uterine Tissue Morphology of Ovariectomized Rats[J].Western Journal of Traditional Chinese Medicine,2021,34(05):30.[doi:10.12174/j.issn.2096-9600.2021.10.07]
[13]赵军,师建平,董重阳,等.蒙药蓝刺头对绝经后骨质疏松症大鼠瘦素、β2肾上腺素受体的影响[J].西部中医药,2021,34(03):72.[doi:10.12174/j.issn.2096-9600.2021.03.19]
　ZHAO Jun,SHI Jianping,DONG Chongyang,et al.Effects of Mongolian Medicine Lancitou on Leptin and β2 Adrenaline Receptors of PMOP Rats[J].Western Journal of Traditional Chinese Medicine,2021,34(05):72.[doi:10.12174/j.issn.2096-9600.2021.03.19]
[14]汪袁凤,吴沛冉,罗莹静,等.针灸治疗绝经后骨质疏松症的研究特点分析[J].西部中医药,2022,35(10):69.[doi:10.12174/j.issn.2096-9600.2022.10.14]
　WANG Yuanfeng,WU Peiran,LUO Yingjing,et al.The Characteristics of the Study on Acupuncture in Treating PMOP[J].Western Journal of Traditional Chinese Medicine,2022,35(05):69.[doi:10.12174/j.issn.2096-9600.2022.10.14]
[15]赵军,李昕,刘岩,等.蒙药蓝刺头对去卵巢大鼠BGP、BMD及股骨组织形态的影响[J].西部中医药,2023,36(06):6.[doi:10.12174/j.issn.2096-9600.2023.06.02]
　ZHAO Jun,LI Xin,LIU Yan,et al.Effects of Mongolian Medicine Lancitou on BGP, BMD and the Morphology of Femur in Ovariectomized Rats[J].Western Journal of Traditional Chinese Medicine,2023,36(05):6.[doi:10.12174/j.issn.2096-9600.2023.06.02]

备注/Memo

备注/Memo:
收稿日期：2019-07-27*基金项目：国家中医药管理局中医药传承与创新“百千万人才工程”项目（J20184832009）；内蒙古医科大学“科技百万工程”联合项目［YKD2017KJBW（LH）064］；内蒙古自治区第三批老蒙医药中医药专家学术经验继承项目（内卫计蒙中字［2019］126）。作者简介：赵军(1988—)，男，硕士学位，主治医师。研究方向：老年病的诊治。△通讯作者：莫日根(1973—)，男，硕士研究生导师，主任医师，副教授。研究方向：肛肠疾病的诊治。
更新日期/Last Update: 2020-05-15